呈和科技（688625）：国产替代持续加速，季度业绩再创新高

Investment Rating - The investment rating for the company is "Buy" and it is maintained [10] Core Views - The company achieved a revenue of 471 million yuan in the first half of 2025, representing a year-on-year increase of 13.8%, and a net profit attributable to shareholders of 147 million yuan, up 15.3% year-on-year [2][7] - In Q2 alone, the company generated a revenue of 251 million yuan, which is a 12.7% increase year-on-year and a 14.0% increase quarter-on-quarter [2][7] - The company's main products, nucleating agents and synthetic hydrotalcite, are key raw materials for producing high-performance resins, and the domestic substitution is accelerating amid global trade policy fluctuations [13] - The company has completed its IPO project and fully utilized its Nansha plant, enhancing its production capacity significantly [13] - The overseas revenue reached 120 million yuan in the first half of 2025, marking a substantial growth of 70.1% year-on-year, indicating a strong international strategy [13] - The company aims to become a "definer" of comprehensive solutions in high polymer materials, enhancing customer satisfaction and loyalty through customized services [13] - The company is a leader in the domestic nucleating agent and synthetic hydrotalcite market, with potential for continued market share growth [13] Financial Summary - The company forecasts net profits of 297 million yuan, 348 million yuan, and 401 million yuan for the years 2025, 2026, and 2027 respectively [13] - The total revenue is projected to reach 1.058 billion yuan in 2025, with a gross profit margin of 44% [19] - The company’s net profit margin is expected to be around 28.1% in 2025 [19]